Despite the dazzle of its spectral capabilities, flow cytometry is helping users focus on their research, clinical, and diagnostic applications.
The CyPath® Lung test employs advanced flow cytometry and artificial intelligence to analyze patient sputum samples for malignancy indicators, achieving 92% sensitivity, 87% specificity ...
SAN ANTONIO, October 30, 2024--bioAffinity Technologies receives a Japanese patent for the method behind the CyPath® Lung ...
The CyPath® Lung test employs advanced flow cytometry and artificial intelligence to analyze patient sputum samples for malignancy indicators, achieving 92% sensitivity, 87% specificity, and 88% ...
Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, announced a substantial expansion of ...
Analyst Michael Matson from Needham reiterated a Buy rating on NeoGenomics (NEO – Research Report) and keeping the price target at ...
NeoGenomics (NEO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Daniel Brennan ...